Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Gola Planta Spray is an herbal oropharyngeal spray developed by Orenda Pharma, primarily indicated for the relief of throat irritation, hoarseness, and dry cough. The product formulation typically combines several natural extracts, including *Erysimum officinale* (Hedge Mustard), *Malva sylvestris* (Mallow), *Aloe vera*, and *Propolis*. *Erysimum* is traditionally known as the singer's plant due to its efficacy in treating laryngitis and restoring the voice. Mallow and Aloe vera provide mucilaginous compounds that create a protective demulcent film over the pharyngeal mucosa, reducing inflammation and shielding the throat from external irritants. Propolis is included for its natural antimicrobial properties, which support the local immune response in the oral cavity. The spray is used as a supportive treatment for conditions such as pharyngitis and vocal strain.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Gola Planta Spray.